Geneos Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5K | Sell |
119
-180
| -60% | -$20.5K | ﹤0.01% | 2201 |
|
|
2025
Q1 | $31.4K | Buy |
299
+238
| +390% | +$25K | ﹤0.01% | 2129 |
|
|
2024
Q4 | $6.54K | Hold |
61
| – | – | ﹤0.01% | 2222 |
|
|
2024
Q3 | $6.11K | Buy |
+61
| New | +$6.11K | ﹤0.01% | 2008 |
|
|
2019
Q4 | – | Sell |
-22
| Closed | -$1K | – | 2563 |
|
|
2019
Q3 | $1K | Hold |
22
| – | – | ﹤0.01% | 2415 |
|
|
2019
Q2 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 2415 |
|
|
2018
Q4 | – | Sell |
-152
| Closed | -$26K | – | 2441 |
|
|
2018
Q3 | $26K | Hold |
152
| – | – | ﹤0.01% | 1460 |
|
|
2018
Q2 | $19K | Buy |
+152
| New | +$19K | ﹤0.01% | 1471 |
|